Dr. Mehmet Oz’s Visit to INVAMED and the Victory of Turkish Engineering

Visit of Dr. Mehmet Öz to INVAMED

Renowned cardiac surgeon Dr. Mehmet Öz visited INVAMED Production and Innovation Campus, Turkey’s leading health technology center, where he experienced the technologies developed in 17 medical branches and the medical devices produced there. Öz evaluated the innovative solutions provided by these devices, especially in the field of vascular surgery, and made important statements regarding the effectiveness of treatment methods and their future promise. Dr. Öz said, “These technologies in Turkey are saving lives.”

The Triumph of Turkish Engineering and a Leader in Global Health Technology

Dr. Mehmet Öz stated during his visit to INVAMED Campus, “What I saw during this visit deeply impressed me. Each medical device is designed and produced entirely in Turkey by INVAMED’s own engineers and technicians. This is not only an indicator of our high technology and innovation power, but also a national success story. Each part of these devices is manufactured by INVAMED, demonstrating how we have strengthened our competitiveness and technological independence on the international stage. The triumph of Turkish engineering positions us as a leader in global health technology. Furthermore, all these products are protected by patents obtained in Turkey, the United States, and Europe. These patents not only provide technological protection but also showcase Turkey’s innovation capability worldwide. Developing our own technology and patenting it internationally are strategic steps that enable us to stand out in the global market. INVAMED shines as a rising star in the global health sector. These achievements are a great honor for Turkish engineering and innovation, constituting a valuable legacy to be passed on to future generations,” he said.

Dr. Öz, while examining the devices developed by INVAMED, stated, “INVAMED is pushing boundaries in health technology. Every innovation I saw here is groundbreaking in the medical world. Through INVAMED, Turkey is emerging as a shining star on the medical technology map.”

• “Venablock and Temren Atherectomy devices are truly revolutionary in the treatment of varicose veins and clearing artery blockages. Treatments with these devices help patients recover faster, significantly improving their quality of life,” said Dr. Öz, emphasizing the contributions of technological innovations to cardiac vascular surgery.

Technological Advancements and Ethical Approach of INVAMED

INVAMED develops devices aiming to improve the quality of life of patients in a wide range of fields from vascular surgery to brain surgery, orthopedics, neurology, oncology, and dermatology. These devices, each designed by expert engineers and doctors in their respective fields, address various needs of modern medicine. INVAMED’s high-tech products in fields such as cardiology, neurology, oncology, and orthopedics are setting new standards in combating diseases. Developed AI-assisted diagnostic tools, surgical robots, and biocompatible implants are revolutionizing the medical field.

• Dr. Öz also mentioned the stent graft and artificial vein technologies developed by INVAMED, saying, “These artificial veins and stent grafts are groundbreaking in vascular surgery. Due to their structures closely resembling real human tissue, they are easily accepted by the body and provide excellent long-term results.”

INVAMED President Raşit Dinç commented on Dr. Öz’s visit and positive feedback on technological advancements, stating, “Receiving positive feedback from a globally renowned expert like Dr. Mehmet Öz for our devices indicates that our efforts are on the right track. Our goal is to make Turkey a leading center in global health technologies.”

Dinç added, “Each of our devices is manufactured in compliance with international regulatory standards and undergoes rigorous quality control processes. This increases the competitiveness of our products in the global market while maximizing the reliability and effectiveness of our medical solutions. INVAMED’s patent portfolio not only protects our technological superiority but also contributes to our national economy’s innovation capacity and strengthens our technological independence. These patents are tangible evidence of investments and innovations in the medical technology field and constitute the strategic assets of our company within the framework of global competitiveness. These strategic assets solidify INVAMED’s position as a market leader both locally and internationally, demonstrating our continuous capacity for innovation in health technologies. Finally, at INVAMED, we embrace sustainable and ethical business practices. This approach supports the long-term success and reputation of our company, ensuring that our solutions to global health issues are ethical and sustainable. These principles transform INVAMED from being just a technology producer into an ethical leader in global health solutions,” he said.